"We are UCI Health: A devoted team of nationally regarded physicians and nurses, researchers and clinicians, educators and students united by a single calling to improve the lives of the people in our community and beyond. As the only academic health system in Orange County, our multifaceted organization is dedicated to the discovery of new medical frontiers, to the teaching of future healers and to the delivery of the finest evidence-based care. We are unique in our ability to provide the most compassionate healthcare because were driven by our passion for innovation, grounded in the best medical and scientific knowledge."

During the past decade, Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 9 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 8 clinical trials were completed. i.e. 27.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center" #1 sponsor was "University of California, Irvine" with 17 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Children's Oncology Group" with 6 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Exelixis" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center" are "Breast Cancer" (6 trials), "Colorectal Cancer" (3 trials), "Endometrial Cancer" (3 trials), "Gastric Adenocarcinoma" (3 trials) and "GastroEsophageal Cancer" (3 trials). Many other conditions were trialed in "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center" in a lesser frequency.

Most popular intervention types in "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center" are "Drug" (68 trials), "Radiation" (15 trials), "Procedure" (10 trials), "Biological" (7 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (9 trials), "Placebo" (7 trials), "cyclophosphamide" (6 trials), "adjuvant therapy" (5 trials) and "cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center" are 59 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center". undefined are not yet recruiting, 24 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center, 17 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".